Home | What is AMD? | Treatment with Visudyne                                      Prescribing Information | Important Safety Information



Important Safety Information


Indications


Visudyne (verteporfin for injection) is used along with laser light treatment to stop leaking from blood vessels in the eye due to the following serious eye conditions: age-related macular degeneration (a condition affecting the retina of the eye which can impair vision), pathologic myopia (extreme nearsightedness) or ocular histoplasmosis (a certain type of fungus infection in the eye).

Important Safety Information

  • Visudyne (verteporfin for injection) should not be used if you have a condition known as porphyria, or if you are allergic to it or any of its components.
  • Avoid exposure of skin and eyes to direct sunlight or bright indoor light for 5 days after treatment with Visudyne by wearing protective clothes and dark sunglasses. A UV sunscreen will not offer enough protection for your skin. Wear a wristband to remind you to do this. However, do not stay in totally dark areas.  You should expose your skin to regular indoor and/or indirect light because doing so will help inactivate the drug in your skin. 
  • In clinical studies, the most common side effects were injection site reactions (such as pain, redness, irritation, and swelling) or changes in vision (including blurred vision and flashes of light).  Tell your doctor about any side effects that you may have. 
  • Do not drive or use machines if you develop or have changes in vision.

​Please see complete Prescribing Information for Visudyne (192.8 KB, PDF).

You are encouraged to report negative side effects of prescription drugs to the FDA.  Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.


Visudyne is a trademark of Novartis AG used under license.

VID.0022.USA.17